📌 Oman Surgical Society update conference 2025 abstract submission format and guidelines

• Title:
  Concise and specific (Max 20 words). Capitalize the first letter of each significant word.

  Presenting Author:
  Full Name, Degrees (e.g., John D. Smith, MD, FRCS)

  Affiliation:
  Institution, Department, City, Country

  Co-authors:
  List all co-authors in the format: First and last names, Degrees, Affiliation

  ---

  Abstract Body (Max 300–350 words)

  Use the following structured format:

  1. Background:
  • Brief context or clinical relevance of the study.
  • Clearly state the topic being addressed.
  2. Objective:
  • A precise statement of the study's purpose or hypothesis.
  3. Methods:
  • Study design (e.g., retrospective cohort, RCT, case series)
  • Sample size, population, duration
  • Key interventions or procedures
  • Outcome measures
  4. Results:
  • Present the main findings (with statistical significance, where applicable)
  • Include key data, not just statements
  5. Conclusion:
  • Interpretation of results
  • Clinical relevance or implications for surgical practice

  ---

  Keywords:

  3–5 keywords (e.g., colorectal cancer, minimally invasive surgery, lymphadenectomy)

  Conflict of Interest Disclosure:

  E.g., "None declared" or specific disclosures

📌 Abstract Submission Guidelines

1. Eligibility:
   • Open to consultants, fellows, residents, and medical students in surgical disciplines, nurses, and other healthcare givers
   • Must be related to general surgery or subspecialties (GI, HPB, endocrine, trauma, etc.)
2. Language:
   • Abstracts must be submitted in English.
3. Formatting Rules:
   • Use a structured format as above.
   • Word limit: 300–350 words (excluding title and affiliations).
   • Do not include tables, images, or graphs in the abstract.
   • Use standard abbreviations (define them at first use).
4. Review Criteria:
   • Scientific merit and originality
   • Relevance to general surgery
   • Methodological rigor
   • Clarity of results and conclusions
5. Submission Process:
   • Deadline: 20/10/2025
   • Notification of acceptance: 15/11/2025
6. Ethics Approval:
   • Clinical studies must demonstrate IRB/ethics committee approval and, if applicable, informed consent.
7. Resubmissions and Edits:
   • Once submitted, abstracts may be edited until the deadline.
   • After the deadline, no changes permitted.